Table 1 Demographic, clinical, and biochemical characteristics of the study groups
Characteristics | Control group (n = 31) | ASTEMI group (n = 92) | P value |
|---|---|---|---|
Sex (male) (%) | 27 (87) | 80 (87) | > 0.999 |
Age (years) | 55 ± 11 | 56 ± 11 | 0.636 |
Body mass index (kg/m2) | 28.7 ± 3.7 | 27.8 ± 4.8 | 0.354 |
Diabetes (%) | 9 (29) | 27 (29) | 0.973 |
Hypertension (%) | 11 (36) | 32 (35) | 0.944 |
Cigarette smoking (%) | 7 (23) | 47 (51) | 0.006 |
Family history of coronary artery disease (%) | 6 (19) | 21 (23) | 0.686 |
Aspirin (%) | 19 (61) | 12 (13) | < 0.001 |
Statins (%) | 17 (55) | 11 (12) | < 0.001 |
Beta-blocker use (%) | 13 (42) | 7 (8) | < 0.001 |
Fasting blood sugar (mg/dL) | 101 (96–136) | 117 (104–160) | 0.014 |
Serum low-density lipoprotein level (mg/dL) | 81 (56–97) | 106 (86–124) | < 0.001 |